What Is Your Actual Risk of HIV?

by Joe Messenger | Mar 28, 2026 | STIs

If you were in school in the 1980s, 1990s, or even the early 2000s, you were likely taught to be absolutely terrified of HIV. That fear sticks. I remember being in college, sitting in my dorm room, talking to a woman from my program on my dorm room phone. Yes, an...

We Sent Gas Station Dick Pills to a Lab — Even We Were Shocked

by Joe Messenger | Mar 24, 2026 | Performance and Desire, Medications and Treatments

Gas Station “Dick Pills”: What’s Actually Inside Big Rhino 10000K, S.W.A.G., and Friends If you’ve ever been inside a late-night gas station, you’ve seen them. Bright packets. Wild claims. Names like Big Rhino 10000K and S.W.A.G. (Sex With A Grudge) that feel less...

Peptide Gray Market Warning: What You Should Know

by Joe Messenger | Mar 24, 2026 | Performance and Desire, Medications and Treatments

What Are Peptides, Really? And Why the “Research Chemical” Market Should Give You Pause We spend a lot of time talking about sexual healthcare. But every once in a while, it’s worth stepping back and explaining something more foundational. Today, that’s peptides....

When Telehealth Marketing Goes Too Far, Everyone Pays the Price

by Joe Messenger | Jan 12, 2026 | Telehealth

A note on perspective Before getting into this, I want to be clear about how this article should be read. This reflects my personal observations and interpretation as a founder operating in the telehealth space. I’m describing patterns I’m seeing and the concerns they...

Why Shameless Care Has Never Offered Semaglutide

by Joe Messenger | Jan 8, 2026 | Prevention and Risk Reduction

Shameless Care launched in May of 2022. Not long after, semaglutide became one of the fastest-growing medications in telehealth. We could have been early. All of our compounding pharmacy partners make semaglutide. We already had a physician network, a telehealth...